Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging a Penn-based Cancer Trial (EA8191) to Assess the Prospective Performance of Artificial Intelligence Augmented Electronic Health Record (EHR) Data Abstraction for Clinical Trial Patient Screening and Selection

NCT06561230 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT06561230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06561230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging a Penn-based Cancer Trial (EA8191) to Assess the Prospective Performance of Artificial Intelligence Augmented Electronic Health Record (EHR) Data Abstraction for Clinical Trial Patient Screening and Selection
Lead sponsor
University of Pennsylvania
Phase
Observational
Overall status
Active, not recruiting
Start date
April 4, 2025
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer